TummyZen Firm Appeals After Heartburn Claims Don't Settle Well In NAD Review
Eli Consumer Healthcare is latest supplement marketer National Advertising Division has advised that tests of separate ingredients do not support claims for a whole product. Following NADs review of TummyZen claims on challenge by Tums firm GlaxoSmithKline, Eli Consumer appeals NAD's recommendations to discontinue claims that its supplement “stops acid production,” is “acid inhibiting,” “halts the secretion of chloride ions in your parietal cells to regulate the release of acid into your stomach,” “supports stomach lining” and is “long lasting."
You may also be interested in...
Eli Nutrition fails in appeal of NAD review of claims for its TummyZen heartburn relief product, with a panel of the National Advertising Review Board concluding the firm overstated its product’s benefits.
Health Club Diet discontinues challenged claims for Androzene male enhancement supplement after NAD criticizes firm for relying on studies on ingredients, not the product. Council for Responsible Nutrition challenged claims as stating an indication for erectile dysfunction drug.
First heartburn remedy with zinc; Invia targets optimal mental energy; and Tauriga rolls with RolLeaf plan.